Johnson & Johnson plans to hunt authorization for a booster dose for its one-shot COVID-19 vaccine early this week, in response to a report by The New York Occasions.
J&J is the final to use for booster authorization among the many makers of the three COVID-19 vaccines used within the US. But, it’s the booster that many well being officers are most desperate to see. The vaccine, which makes use of a viral vector technique relatively than an mRNA-based design, is the one accessible COVID-19 vaccine given as only one shot. Its efficacy has lagged behind the opposite vaccines all through the pandemic.
Nonetheless, Moderna and Pfizer-BioNTech, each mRNA-based vaccine, have already submitted booster functions to US regulators. On September 22, the Meals and Drug Administration granted authorization for a booster dose of the Pfizer-BioNTech vaccine for sure teams of individuals. The choice was tense, with consultants torn over whether or not a booster for the extremely efficient vaccine was broadly wanted.
Learn 6 remaining paragraphs | Feedback